Tandem Diabetes Care Announces First Quarter 2023 Financial Results and Reaffirms Full Year 2023 Financial Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/13/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. CRM
9. MSFT
10. CRWV

Go back to Tandem Diabetes Care Announces First Quarter 2023 Financial Results and Reaffirms Full Year 2023 Financial Guidance

Tandem Diabetes (TNDM) Misses Q1 EPS by 9c; Reaffirms

May 3, 2023 4:18 PM EDT

Tandem Diabetes (NASDAQ: TNDM) reported Q1 EPS of ($0.63), $0.09 worse than the analyst estimate of ($0.54). Revenue for the quarter came in at $171.41 million versus the consensus estimate of $169.83 million.

GUIDANCE:

Tandem Diabetes reaffirms FY2023 revenue of $885-900 million.

For earnings history and earnings-related data on Tandem Diabetes (TNDM) click here.

... More